University of California, Davis
Profiles
Home
About
Help/FAQs
History (0)
Search Options
UC Davis
UCI
UCLA
UCSD
UCSF
All UC Health
USC
All
Everything
Research
Concepts
Awards
People
UC Health People
UC Davis People
UCI People
UCLA People
UCSD People
UCSF People
USC People
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sidney Scudder
Concepts (205)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Adenocarcinoma
Adenocarcinoma, Clear Cell
Administration, Oral
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Algorithms
Alkylating Agents
Amifostine
Angiogenesis Inhibitors
Animals
Antibiotics, Antineoplastic
Antibodies
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anticoagulants
Antigens, Neoplasm
Antigens, Tumor-Associated, Carbohydrate
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Bias
Biomarkers, Tumor
Biopsy, Needle
Brachytherapy
Brain Neoplasms
Brenner Tumor
CA-125 Antigen
California
Carboplatin
Carcinoma
Carcinoma, Non-Small-Cell Lung
Carcinoma, Renal Cell
Carcinoma, Squamous Cell
Carcinoma, Transitional Cell
Case-Control Studies
Cell Line, Tumor
Cell Survival
Cell-Free Nucleic Acids
Chemotherapy, Adjuvant
Chicago
Chorionic Gonadotropin
Chorionic Gonadotropin, beta Subunit, Human
Circulating Tumor DNA
Cisplatin
Clinical Protocols
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cohort Studies
Combined Modality Therapy
Confidence Intervals
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Cyclophosphamide
Cyclosporine
Cystadenocarcinoma, Serous
Decision Making
Deoxycytidine
Disease-Free Survival
DNA
DNA Mutational Analysis
DNA, Neoplasm
Dose-Response Relationship, Drug
Doxorubicin
Drug Administration Schedule
Drug Evaluation
Drug Resistance
Drug Resistance, Neoplasm
Drug Synergism
Drug Therapy, Combination
Eligibility Determination
Endometrial Neoplasms
Endometriosis
ErbB Receptors
Erlotinib Hydrochloride
Erythropoietin
E-Selectin
Europe
Evaluation Studies as Topic
Female
Fluorouracil
Follicle Stimulating Hormone
Follow-Up Studies
Gene Dosage
Genital Diseases, Female
Genital Neoplasms, Female
Geography
Glutamates
Groin
Guanine
Health Services Accessibility
High-Throughput Nucleotide Sequencing
Humans
Hysterectomy
Immunoenzyme Techniques
Incidence
Information Services
Infusions, Intravenous
Injections, Intravenous
Injections, Subcutaneous
Insurance Coverage
Insurance, Health
Insurance, Health, Reimbursement
Interferon-alpha
Interleukin-2
Isotretinoin
Kaplan-Meier Estimate
Ki-67 Antigen
Kidney Neoplasms
Liquid Biopsy
Logistic Models
Longitudinal Studies
Lung Neoplasms
Luteinizing Hormone
Lymph Node Excision
Lymphatic Metastasis
Magnetic Resonance Imaging
Male
Maximum Tolerated Dose
Medical Records
Megestrol
Megestrol Acetate
Melanoma
Middle Aged
Mitoxantrone
Models, Genetic
Multicenter Studies as Topic
Multivariate Analysis
Mutation
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms, Multiple Primary
Ovarian Neoplasms
Paclitaxel
Patient Participation
Patient Selection
Pelvic Neoplasms
Pemetrexed
Peptide Fragments
Peritoneal Neoplasms
Physician-Patient Relations
Pilot Projects
Plasma
Platinum Compounds
Polyethylene Glycols
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
Postoperative Period
Prognosis
Prospective Studies
Protein Kinase Inhibitors
Quinazolines
Rabbits
Radiotherapy
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic
Real-Time Polymerase Chain Reaction
Recombinant Fusion Proteins
Recombinant Proteins
Recurrence
Reference Values
Referral and Consultation
Refusal to Participate
Registries
Reproducibility of Results
Research Subjects
Retrospective Studies
Risk Assessment
Risk Factors
ROC Curve
Salvage Therapy
Sensitivity and Specificity
Severity of Illness Index
Stem Cell Transplantation
Surveys and Questionnaires
Survival Analysis
Survival Rate
Thiotepa
Thrombosis
Thrombospondin 1
Time Factors
Tomography, X-Ray Computed
Topoisomerase I Inhibitors
Topotecan
Treatment Outcome
Tretinoin
Triazines
Tumor Cells, Cultured
Tumor Stem Cell Assay
Tumor Suppressor Protein p53
Urologic Diseases
Uterine Cervical Neoplasms
Vaginal Neoplasms
Vascular Endothelial Growth Factor A
Venous Thrombosis
Vulvar Neoplasms
Warfarin
Sidney's Networks
Concepts (205)
Derived automatically from this person's publications.
Real-Time Polymerase Chain Reaction
Plasma
Carcinoma, Non-Small-Cell Lung
Ovarian Neoplasms
Lung Neoplasms
Explore
_
Co-Authors (19)
People in Profiles who have published with this person.
Leiserowitz, Gary
UC Davis
Gandara, David
UC Davis
Wun, Theodore
UC Davis
Smith, Lloyd
UC Davis
Lara, Primo
UC Davis
Explore
_
Similar People (60)
People who share similar concepts with this person.
Gandara, David
UC Davis
Matsuo, Koji
USC
Garon, Edward
UCLA
Hoffman, Robert
UCSD
Tewari, Krishnansu
UCI
Explore
_
Same Department
DeNardo, Gerald
Giermasz, Adam
Kaesberg, Paul
Keegan, Theresa
Lau, Derick
Search Department
_